Cumulative people who have received a company's implanted brain-computer interface — the clearest sign the field has moved from animals to humans. Synchron leads with 10 recipients; Neuralink has implanted 5.
Roughly sixteen people carry a company's brain implant. In 2026 the field crossed from trials into products: China approved and implanted the first commercial invasive BCI, and Europe cleared the first BCI to restore reading vision — both ahead of Neuralink.
Demos and valuations are easy to inflate; people living with an implant are not. The count of humans implanted is the hardest signal that a BCI has crossed from lab to clinic — and Synchron, not the loudest name, leads it.
No coverage matches this filter yet.
Neuralink 
Synchron 
Paradromics